SEC 13F Intelligence

Nkcfo LLC / GILD

Nkcfo LLC’s Gilead Sciences Inc Position

Does Nkcfo LLC own Gilead Sciences Inc (GILD)? Not currently — the last reported position was 60.6K shares worth $7M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q4 2025
Shares
60.6K
% of Portfolio
+2.15%
Quarters Held
5
position exited

Position History GILD

Reported value by quarter
Q4 ’24: $3MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $7MQ3 ’25Q4 ’25: $7MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202560.6K$7M+2.15%
Q3 202562.3K$7M+2.08%
Q2 202544.1K$5M+2.04%
Q1 202544.1K$5M+2.30%
Q4 202429.7K$3M+1.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nkcfo LLC’s full portfolio or all institutional holders of GILD.